Clinical outcomes of per‐oral endoscopic tumor resection for submucosal tumors in the esophagus and gastric cardia

2020 ◽  
Vol 32 (3) ◽  
pp. 328-336 ◽  
Author(s):  
Manabu Onimaru ◽  
Haruhiro Inoue ◽  
Robert Bechara ◽  
Mayo Tanabe ◽  
Mary Raina Angeli Abad ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Tumor Resection ◽  
Gastric Cardia ◽  
Submucosal Tumors ◽  
Endoscopic Tumor Resection ◽  
Per Oral

scholarly journals Sa1936 CLINICAL OUTCOME OF PER-ORAL ENDOSCOPIC TUMOR RESECTION FOR SUBMUCOSAL TUMORS OF THE ESOPHAGUS AND GASTRIC CARDIA

2018 ◽  
Vol 87 (6) ◽  
pp. AB257
Author(s):  
Mayo Tanabe ◽  
Shin Kono ◽  
Masaki Ominami ◽  
Masayuki Nishimoto ◽  
Yohei Nishikawa ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Tumor Resection ◽  
Gastric Cardia ◽  
Submucosal Tumors ◽  
Endoscopic Tumor Resection ◽  
Per Oral

Mo1969 Per-Oral Endoscopic Tumor Resection for Submucosal Tumors of the Esophageal and Gastric Cardia

2017 ◽  
Vol 85 (5) ◽  
pp. AB499
Author(s):  
Masaki Ominami ◽  
Kazuya Sumi ◽  
Tetsuya Tatsuta ◽  
Yuichiro Ikebuchi ◽  
Haruo Ikeda ◽  
...  
Keyword(s):  
Tumor Resection ◽  
Gastric Cardia ◽  
Submucosal Tumors ◽  
Endoscopic Tumor Resection ◽  
Per Oral

Sa1244 An Innovative Ex-Vivo Porcine Upper GI Model for Per Oral Endoscopic Tumor Resection (Poet)

2016 ◽  
Vol 83 (5) ◽  
pp. AB270-AB271
Author(s):  
Baldwin P. Yeung ◽  
Philip W. Chiu ◽  
Anthony Y. Teoh ◽  
Linfu Zheng ◽  
Shannon M. Chan ◽  
...  
Keyword(s):  
Ex Vivo ◽  
Tumor Resection ◽  
Upper Gi ◽  
Endoscopic Tumor Resection ◽  
Per Oral

scholarly journals Gastric microbiota features associated with cancer risk factors and clinical outcomes: A pilot study in gastric cardia cancer patients from Shanxi, China

2017 ◽  
Vol 141 (1) ◽  
pp. 45-51 ◽  
Author(s):  
Guoqin Yu ◽  
Nan Hu ◽  
Lemin Wang ◽  
Chaoyu Wang ◽  
Xiao-You Han ◽  
...  
Keyword(s):  
Risk Factors ◽  
Pilot Study ◽  
Cancer Risk ◽  
Cancer Patients ◽  
Clinical Outcomes ◽  
Gastric Cardia ◽  
Cardia Cancer ◽  
Cancer Risk Factors ◽  
Gastric Cardia Cancer ◽  
Gastric Microbiota

Clinical outcomes of laparoscopic partial gastrectomy for gastric submucosal tumors

2014 ◽  
Vol 8 (1) ◽  
pp. 24-28 ◽  
Author(s):  
Masashi Hirota ◽  
Kiyokazu Nakajima ◽  
Yasuhiro Miyazaki ◽  
Tsuyoshi Takahashi ◽  
Yukinori Kurokawa ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Partial Gastrectomy ◽  
Submucosal Tumors ◽  
Gastric Submucosal Tumors

scholarly journals Clinical outcomes and safety of high-resolution manometry guided superficial partial circular muscle myotomy in per-oral endoscopic myotomy for Jackhammer esophagus: Two cases report

2019 ◽  
Vol 7 (16) ◽  
pp. 2322-2329
Author(s):  
Youn I Choi ◽  
Kyoung Oh Kim ◽  
Dong Kyun Park ◽  
Jun-Won Chung ◽  
Yoon Jae Kim ◽  
...  
Keyword(s):  
High Resolution ◽  
Clinical Outcomes ◽  
Circular Muscle ◽  
High Resolution Manometry ◽  
Per Oral Endoscopic Myotomy ◽  
Endoscopic Myotomy ◽  
Per Oral

scholarly journals Sa1237 INITIAL EXPERIENCE WITH SAME SESSION ENDOSCOPIC FUNDOPLICATION AFTER PER-ORAL ENDOSCOPIC MYOTOMY (POEM+F) – SHORT TERM CLINICAL OUTCOMES FROM A SINGLE CENTER

2020 ◽  
Vol 91 (6) ◽  
pp. AB124
Author(s):  
Amol Bapaye ◽  
Siddharth Dharamsi ◽  
Parag Dashatwar ◽  
Rajendra Pujari ◽  
Harshal P. Gadhikar
Keyword(s):  
Clinical Outcomes ◽  
Initial Experience ◽  
Single Center ◽  
Short Term ◽  
Per Oral Endoscopic Myotomy ◽  
Endoscopic Myotomy ◽  
Endoscopic Fundoplication ◽  
Per Oral

scholarly journals Endoscopic tumor resection of the inferior vena cava

2006 ◽  
Vol 132 (3) ◽  
pp. 687-688 ◽  
Author(s):  
H. Jeanmart ◽  
P. Lecompte ◽  
F. Casselman ◽  
J. Coddens ◽  
G. Van Vaerenberg ◽  
...  
Keyword(s):  
Inferior Vena Cava ◽  
Inferior Vena ◽  
Tumor Resection ◽  
Vena Cava ◽  
Endoscopic Tumor Resection

1674 RISK OF COMPLICATIONS OF PERIOPERATIVE MITOMYCIN (MMC) AMONG BLADDER CANCER PATIENTS UNDERGOING ENDOSCOPIC TUMOR RESECTION

2012 ◽  
Vol 187 (4S) ◽  
Author(s):  
Christopher Filson ◽  
Jeffrey Montgomery ◽  
Stephen Dailey ◽  
Heather Crossley ◽  
Paul Al-Attar ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Patients ◽  
Tumor Resection ◽  
Endoscopic Tumor Resection

scholarly journals Outcomes of Surgically Treated Giant Pituitary Tumours

2012 ◽  
Vol 39 (4) ◽  
pp. 446-457 ◽  
Author(s):  
Michael D. Cusimano ◽  
Peter Kan ◽  
Farshad Nassiri ◽  
Jennifer Anderson ◽  
Jeannette Goguen ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Surgical Complications ◽  
Transsphenoidal Surgery ◽  
Tumor Volume ◽  
Tumor Resection ◽  
Pituitary Tumours ◽  
Median Length ◽  
Recurrence Rates ◽  
Endoscopic Transsphenoidal Surgery

Objective:To evaluate the outcomes of patients with giant pituitary tumours (GPTs) who underwent a purely binasal endoscopic transsphenoidal surgery (BETS) and compare their outcomes with those achieved through craniotomy and microscopic transsphenoidal surgery (MTS).Methods:Seventy-two consecutive patients with GPTs (greater than 10 cm3 in volume) who were treated surgically with BETS, craniotomy, or MTS from October 1994 to July 2009 were reviewed for clinical outcomes, degree of tumor resection, recurrence rates, and surgical complications.Results:The BETS group had significantly better mean reduction of tumor volume (91%) than the craniotomy (63%, p = 0.001), and the MTS (63%, p = 0.010) groups. Gross total resection rates were also higher for BETS patients than for craniotomy patients (p = 0.010). Improvements in vision and headaches were noted in 96% and 100% of patients in the BETS group, respectively; these rates were similar to those in the craniotomy and MTS groups. Of the four patients with hormone-secreting tumours in the BETS group, three remained in remission. The median length-of-stay (four days) for the BETS group was shorter (p = 0.010), and surgical complications were less frequent (p = 0.037) and less severe compared to the craniotomy group. There were no differences in the recurrence rates: 79% percent of patients in the BETS group, 69% in the craniotomy group, and 79% in the MTS group were recurrence free at last follow-up (p = 0.829).Conclusions:Treatment of GPT with BETS offers excellent oncologic and clinical outcomes and can frequently obviate the need for craniotomy in these patients.

Sign in / Sign up

Export Citation Format

Share Document